Tesla
TSLA
Adobe
ADBE
Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
US Stock MarketDetailed Quotes
DHR Danaher
- 212.400
- -0.400-0.19%
Close Mar 25 16:00 ET
151.80BMarket Cap40.15P/E (TTM)
214.190High210.370Low3.08MVolume212.850Open212.800Pre Close653.78MTurnover0.49%Turnover Ratio40.15P/E (Static)714.71MShares281.09452wk High3.06P/B134.73BFloat Cap196.80052wk Low1.08Dividend TTM634.31MShs Float291.894Historical High0.51%Div YieldTTM1.80%Amplitude3.985Historical Low212.454Avg Price1Lot Size
About Danaher Company
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
Company Profile
SymbolDHR
Company NameDanaher
Listing DateDec 10, 1969
Founded1984
CEOMr. Rainer M. Blair
MarketNYSE
Employees63000
Fiscal Year Ends12-31
Address2200 Pennsylvania Avenue North West,Suite 800 West
CityWashington
ProvinceDistrict of Columbia
CountryUnited States of America
Zip Code20037-1701
Phone1-202-828-0850
Websitehttp://www.danaher.com
Company Executives
- Name
- Position
- Salary
- Rainer M. Blair
- Director, President and Chief Executive Officer
- 20.90M
- Christopher M. Bouda
- Vice President and Chief Accounting Officer
- --
- Matthew R. McGrew
- Executive Vice President and Chief Financial Officer
- 7.50M
- Dr. Jose-Carlos Gutierrez-Ramos, PhD
- Senior Vice President and Chief Scientific Officer
- 7.20M
- R. Bradley Gray
- Senior Vice President, Strategic Development
- --
- Daniel A. Raskas
- Senior Vice President, Corporate Development
- --
- Christopher Paul Riley
- Executive Vice President
- --
- Brian W. Ellis
- Senior Vice President and General Counsel
- --
- Julie A. Sawyer Montgomery
- Executive Vice President
- --
- Georgeann F. Couchara
- Senior Vice President, Human Resources
- 5.25M
- Steven M. Rales
- Chairman of the Board
- --
- Mitchell P. Rales
- Director
- --
- Professor Raymond C. Stevens, PhD
- Independent Director
- 318.13K
- Alan G. Spoon, J.D.
- Independent Director
- 338.13K
- Feroz Dewan
- Independent Director
- 318.13K
- Dr. Jessica L. Mega, M.D.,M.P.H.
- Independent Director
- 318.13K
- Dr. Elias A. Zerhouni, M.D.
- Independent Director
- 338.13K
- Linda Hefner Filler
- Lead Independent Director
- 382.13K
- Charles W. Lamanna
- Independent Director
- --
- Teri L. List-Stoll
- Independent Director
- 318.13K
- A. Shane Sanders
- Independent Director
- 320.13K
- John T. Schwieters
- Independent Director
- 351.13K
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.